BGI Genomics Monthly Spotlight - September 2024
BGI Genomics
BGI Genomics, based in China, is the world’s leading provider of genetic tests and sequencing services.
Joining Forces to Prevent Colorectal Cancer and Chronic Diseases | ICG19·MH Roundup
Throwback to our insightful discussions on colorectal cancer prevention and the power of metagenomics! 🌍
We gathered over 20 experts from 7 countries to dive into the latest advancements in metagenomics, disease prediction, and microbiome-based health interventions at the ICG19·MH and the 2nd MOHA Alliance Meeting in Harbin on September 20-21!
💡 9 expert, 1 key takeaway: early detection and timely intervention will help reduce both the incidence and mortality rates of colorectal cancer worldwide.
Bringing Precision Medicine to Life in Latin America | Hans Story
👨🔬 Meet Hans Garcia Garces, our Field Application Scientist based in vibrant São Paulo. 🇧🇷
This relentless Havana native is dedicated to bringing the benefits of genomics to communities across Latin America and making advanced healthcare more accessible, all while balancing his love for staying active and the outdoors. 🏞️
Kazakhstan's Health Minister and Presidential Advisor Visit Headquarter of BGI Genomics for Collaboration Opportunities
🌟Big steps forward for precision medicine in Kazakhstan 🌟
The Advisor on Science and Innovation to the President of Kazakhstan and the Minister of Health's recent visit to our headquarters offered an invaluable opportunity to expand access to better healthcare solutions for more individuals across the region.
Recommended by LinkedIn
Whole Genome Sequencing is Transforming Fight Against Childhood Cancer
💡 DYK that childhood cancers behave differently from adult cancers? These differences in both type and behavior lead to the need for unique treatments. Whole Genome Sequencing (WGS) is transforming pediatric cancer care by uncovering new ways to treat high-risk pediatric cases.
Scout's story of survival is a powerful example of how precision medicine can change lives. By identifying the genetic causes of her cancer, doctors were able to provide a targeted treatment that gave her a new lease on life.
Rwandan Delegation Visits BGI Genomics to Strengthen Public Health Cooperation
It was a true pleasure to welcome Rwanda's Minister of Health, Dr. Sabin Nsanzimana, to our Shenzhen headquarters on September 8th! ✨
This visit was a great opportunity to discuss how to leverage BGI Genomics' expertise for the betterment of Rwanda healthcare infrastructure, such as the cervical cancer program we initiated last April in the country
Genetic Screening Revolutionizes Prenatal Diagnosis of Congenital Heart Disease | BGI Insight
A new study published in Frontiers in Genetics has demonstrated the effectiveness of combining CNVs-seq and Whole Exome Sequencing (WES) in detecting congenital heart diseases (CHDs)—the most prevalent birth defect and a significant cause of newborn mortality.
Jointly conducted by BGI Genomics and the Prenatal Diagnosis Center of the Women and Children’s Hospital of Xiamen University, the research has identified critical genes such as TMEM67, PLD1, ANKRD11, and PNKP that contribute to CHDs.